Feilong Yang
7PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 10, 2026
ERMP1 Exerts Tumor-Suppressive Functions in KIRC by Inhibiting PI3K/AKT Signaling and Remodeling the Immune Microenvironment: A Pan-Cancer Analysis.Ziyang Liu, Jiahao Shan, Tao Yang
|Feb 25, 2021
Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.Feilong Yang, Guojiang Zhao, Liyuan Ge
|Oct 22, 2020
Long non-coding RNA LINC01234 regulates proliferation, migration and invasion via HIF-2α pathways in clear cell renal cell carcinoma cells.Feilong Yang, Cheng Liu, Guojiang Zhao
|Jul 07, 2020
The influence of venous tumor thrombus combined with bland thrombus on the surgical treatment and prognosis of renal cell carcinoma patients.Zhuo Liu, Li Zhang, Peng Hong
|May 24, 2018
Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors.Hui Wang, Lijian Gao, Cuiyu Meng
|Jan 05, 2018
Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.Feilong Yang, Nengwang Yu, Hui Wang
Pageof 2
